The announcement imo should have been declared that reiterated the take up of health care professionals is forecast to be very strong. So, Sonic now has to do more work to ensure there is adequate pathology centres ready and able to handle the tests. Therefore, the roll out now has to be more thorough than initially thought, which will take extra time. That would've at least allayed some concerns, to investors, that PromarkerD is very needed by the US healthcare system strategy for diabetics going forward.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)